Search

everythinglearnresearchcommunity

for

Search:↓

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Baricitinib may effectively treat oral lichen planus.

Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.

Minoxidil with propranolol and diuretics lowers blood pressure but causes fluid retention and hair growth.

Sumatriptan injections, high-flow oxygen, and verapamil effectively treat cluster headaches.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Hair growth is influenced by various body and external factors, and neighboring hairs communicate to synchronize regeneration.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Vitamin A toxicity can cause severe health issues and may require a liver transplant if other treatments fail.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Skin stem cells are maintained by signals from nearby cells and vary in their ability to renew and mature.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

The drug combination was safe and showed promise in treating advanced tumors.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

New treatments for vitiligo show promise but still face challenges, especially for hands and feet.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.